Urology
Volume 74, Issue 5 , Pages 968-971 , November 2009

Choosing Health, Choosing Treatment: Patient Choice After Diagnosis of Localized Prostate Cancer

  • Peter Branney

      Affiliations

    • Centre for Men's Health, Leeds Metropolitan University, Leeds, West Yorkshire, United Kingdom
    • Corresponding Author InformationReprint requests: Peter Branney, Ph.D., Centre for Men's Health, Leeds Metropolitan University, Queen Square House, Leeds, LS2 8AF United Kingdom
    • ,
  • Alan White

      Affiliations

    • Centre for Men's Health, Leeds Metropolitan University, Leeds, West Yorkshire, United Kingdom
    • ,
  • Sunjay Jain

      Affiliations

    • Pyrah Department of Urology, St. James Hospital, Leeds Teaching Hospitals National Health Service Trust, Leeds, United Kingdom, London, United Kingdom
    • ,
  • Chris Hiley

      Affiliations

    • Pyrah Department of Urology, St. James Hospital, Leeds Teaching Hospitals National Health Service Trust, Leeds, United Kingdom, London, United Kingdom
    • ,
  • Paul Flowers

      Affiliations

    • Department of Psychology, Glasgow Caledonian University, Glasgow, United Kingdom

Received 3 February 2009 ,Accepted 8 March 2009.

References 

  1. Steer PJ. So what's new about patient choice?. BMJ. 2006;332:981
  2. Davison BJ, Oliffe JL, Pickles T, et al. Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer. Oncol Nurs Forum. 2009;36:89–96
  3. Broom A. The eMale: prostate cancer, masculinity and online support as a challenge to medical expertise. Sociology. 2005;41:87–104
  4. Volk R, Cass A, Spann S. A randomized controlled trial of shared decision making for prostate cancer screening. Arch Fam Med. 1999;8:833–840
  5. Davison BJ, Goldenberg SL, Gleave ME, et al. Provision of individualized information to men and their partners to facilitate treatment decision making in prostate cancer. Oncol Nurs Forum. 2003;30:107–114
  6. Parker PA, Davison BJ, Tishelman C, et al. SCRN Communication Team What do we know about facilitating patient communication in the cancer care setting?. Psychooncology. 2005;14:848–858
  7. Owens J, White AK, Kelsey S. How was it for you? (Men, prostate cancer and radiotherapy). J Radiother Practice. 2004;3:167–174
  8. Davison BJ. Utilizing research to guide clinical practice in prostate cancer education. Oncol Nurs Forum. 2003;30:377–379
  9. Fowler FJ, Naughton Collins M, Albertsen PC, et al. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. JAMA. 2000;283:3217–3222
  10. Litwin MS, Gore JL, Kwan L, et al. Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer. Cancer. 2007;109:2239–2247
  11. Chapple A, Ziebland S. Prostate cancer: embodied experience and perceptions of masculinity. Sociol Health Illn. 2002;24:820–841
  12. Oliffe J. Constructions of masculinity following prostatectomy-induced impotence. Soc Sci Med. 2005;60:2240–2259
  13. Heidenreich A, Aus GBM, Joniau S, et al. EAU guidelines on prostate cancer. Eur Urol. 2008;53:68–80
  14. Lane JA, Donovan J, Neal D, et al. ProtecT Study Group The ProtecT trial: evaluating the effectiveness of treatments for clinically localised prostate cancer and associated molecular and genetic epidemiology studies. Eur Urol Suppl. 2007;6:182
  15. National Institute for Health and Clinical Excellence. Prostate Cancer: Diagnosis and Treatment. London: National Institute for Health and Clinical Excellence; 2008;
  16. Broom A. Prostate cancer and masculinities in Australia. In:  Gough B,  Robertson S editor. Men, Masculinities and Health: Critical Perspectives. Basingstoke, UK: Palgrave; 2009;
  17. Kunkel E, Bakker J, Myers R, et al. Biopsychosocial aspects of prostate cancer. Psychosomatics. 2000;41:85–94
  18. Robertson S. “I've been like a coiled spring this last week”: embodied masculinity and health. Sociol Health Illn. 2006;28:433–456
  19. Sanda MG, Rodney L, Dunn J, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med. 2008;358:1250–1261
  20. Lu-Yao G, Albertsen P, Stanford J, et al. Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and Connecticut. BMJ. 2002;325:740
  21. Gilbert SM. Reliable measurement in urology: room for improvement. Eur Urol. 2007;52:1–2
  22. Corner J, Wright D, Hopkinson J, et al. The research priorities of patients attending UK cancer treatment centres: findings from a modified nominal group study. Br J Cancer. 2007;96:875–881
  23. Oliffe JL, Davison BJ, Pickles T, et al. The self-management of uncertainty among men undertaking active surveillance for low risk prostate cancer. Qual Health Res. 2009;19:432–443
  24. National Audit Office. Tackling Cancer: Improving the Patient Journey. London: HMSO; 2005;
  25. Department of Health. Research Governance Framework. London: Stationary Office; 2005;

 P. Branney received a grant from the U.K. Department of Health and has made grant applications to the Prostate Cancer Charity; S. Jain, P. Flowers, and A. White have made grant applications to the Prostate Cancer Charity; and C. Hiley was Head of Policy and Research at the U.K. Prostate Cancer Charity.

PII: S0090-4295(09)00354-9

doi: 10.1016/j.urology.2009.03.015

Urology
Volume 74, Issue 5 , Pages 968-971 , November 2009

Article Tools